Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain

Author(s): Cristina Buigues, Ana Queralt, Jose A. De Velasco, Antonio Salvador-Sanz, Catriona Jennings, David Wood and Isabel Trapero*

Volume 20, Issue 9, 2020

Page: [1412 - 1418] Pages: 7

DOI: 10.2174/1871530320666200610161344

Price: $65

Abstract

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are an established model of care designed to improve risk factor management. They have been successfully implemented in a variety of settings, in patients with coronary heart disease (CHD).

Objective: To assess the long term impact of a nurse-coordinated, multidisciplinary, CVPRP in patients with CHD in the reduction of lipid profile and medication prescription in clinical practice.

Methods: The study used an analytical, experimental, population based, prospective and longitudinal design. In Spain, the study was conducted in the Valencian Community, including two randomized hospitals. Coronary patients were prospectively and consecutively identified in both hospitals. The intervention hospital carried out an 8-week CVPRP.

Results: The proportion of patients achieving improved standards of preventive care increased in the intervention hospital compared with the usual care hospital, mainly regarding LDL-C concentrations. Furthermore, an increased prescription of statins was found in the intervention group. However, there were no statistically significant differences in triglycerides and glucose levels.

Conclusion: The EUROACTION nurse-led CVPRP enabled coronary patients to control lipid profile to the European targets. A large proportion of patients were prescribed statin therapy as cardioprotective medication with favorable changes in medication for coronary patients. To improve the potential for cardiovascular prevention, we need local preventive cardiology programmes adapted to the health policy of individual countries.

Keywords: Nursing, cardiovascular prevention and rehabilitation programmes, interdisciplinary, coronary heart disease, lipid profile.

« Previous Next »
Graphical Abstract

[1]
Wilkins, E.; Wilson, L.; Wickramasinghe, K.; Bhatnagar, P.; Leal, J.; Luengo-Fernandez, R.; Burns, R.; Rayner, M.; Townsend, N. European Cardiovascular Disease Statistics 2017 2017.
[2]
Mach, F.; Baigent, C.; Catapano, A.L.; Koskinas, K.C.; Casula, M.; Badimon, L.; Chapman, M.J.; De Backer, G.G.; Delgado, V.; Ference, B.A. ESC/EAS Guidelines for the management of Dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J., 2019, 2019, 1-78.
[http://dx.doi.org/10.1093/eurheartj/ehz455 ] [PMID: 31504418]
[3]
Kotseva, K.; Wood, D.; De Backer, G.; De Bacquer, D.; Pyörälä, K.; Keil, U. EUROASPIRE Study Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet, 2009, 373(9667), 929-940.
[http://dx.doi.org/10.1016/S0140-6736(09)60330-5 ] [PMID: 19286092]
[4]
Kotseva, K.; De Backer, G.; De Bacquer, D.; Rydén, L.; Hoes, A.; Grobbee, D.; Maggioni, A.; Marques-Vidal, P.; Jennings, C.; Abreu, A.; Aguiar, C.; Badariene, J.; Bruthans, J.; Castro Conde, A.; Cifkova, R.; Crowley, J.; Davletov, K.; Deckers, J.; De Smedt, D.; De Sutter, J.; Dilic, M.; Dolzhenko, M.; Dzerve, V.; Erglis, A.; Fras, Z.; Gaita, D.; Gotcheva, N.; Heuschmann, P.; Hasan-Ali, H.; Jankowski, P.; Lalic, N.; Lehto, S.; Lovic, D.; Mancas, S.; Mellbin, L.; Milicic, D.; Mirrakhimov, E.; Oganov, R.; Pogosova, N.; Reiner, Z.; Stöerk, S.; Tokgözoğlu, L.; Tsioufis, C.; Vulic, D.; Wood, D. EUROASPIRE Investigators*. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur. J. Prev. Cardiol., 2019, 26(8), 824-835.
[http://dx.doi.org/10.1177/2047487318825350 ] [PMID: 30739508]
[5]
Wood, D.A.; Kotseva, K.; Connolly, S.; Jennings, C.; Mead, A.; Jones, J.; Holden, A.; De Bacquer, D.; Collier, T.; De Backer, G.; Faergeman, O. EUROACTION Study Group Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet, 2008, 371(9629), 1999-2012.
[http://dx.doi.org/10.1016/S0140-6736(08)60868-5 ] [PMID: 18555911]
[6]
Wood, D.; De Backer, G.; Faergeman, O.; Graham, I.; Mancia, G.; Pyörälä, K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis, 1998, 140(2), 199-270.
[http://dx.doi.org/10.1016/S0021-9150(98)90209-X ] [PMID: 9862269]
[7]
Wood, D.A.; Kotseva, K.; Jennings, C.; Mead, A.; Jones, J.; Holden, A.; Connolly, S.; De Bacquer, D.; De Backer, G.; Study, E. EUROACTION : A European Society of Cardiology Demonstration Project in preventive cardiology a cluster randomised controlled trial of a multi-disciplinary preventive cardiology programme for coronary patients, asymptomatic high risk individuals and their families. Summary of design, methodology and outcomes. Eur. Heart J. Suppl., 2004, 6, 3-15.
[http://dx.doi.org/10.1093/eurheartj/6.suppl_j.j3]]
[8]
Brugts, J.J.; Yetgin, T.; Hoeks, S.E.; Gotto, A.M.; Shepherd, J.; Westendorp, R.G.J.; de Craen, A.J.M.; Knopp, R.H.; Nakamura, H.; Ridker, P.; van Domburg, R.; Deckers, J.W. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ, 2009, 338(7711), b2376.
[http://dx.doi.org/10.1136/bmj.b2376 ] [PMID: 19567909]
[9]
Gencer, B.; Rigamonti, F.; Nanchen, D.; Vuilleumier, N.; Kern, I.; Aghlmandi, S.; Klingenberg, R.; Räber, L.; Auer, R.; Carballo, D.; Carballo, S.; Heg, D.; Windecker, S.; Lüscher, T.F.; Matter, C.M.; Rodondi, N.; Mach, F. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. Eur. J. Clin. Invest., 2019, 49(7)e13117
[http://dx.doi.org/10.1111/eci.13117 ] [PMID: 30937890]
[10]
Kumar, N.; Kumar, S.; Kumar, A.; Shakoor, T.; Rizwan, A. Lipid profile of patients with Acute Myocardial Infarction (AMI). Cureus, 2019, 11(3)e4265
[http://dx.doi.org/10.7759/cureus.4265 ] [PMID: 31139524]
[11]
Janssen, V.; De Gucht, V.; Dusseldorp, E.; Maes, S. Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Prev. Cardiol., 2013, 20(4), 620-640.
[http://dx.doi.org/10.1177/2047487312462824 ] [PMID: 23022703]
[12]
Dagenais, G.R.; Yi, Q.; Mann, J.F.E.; Bosch, J.; Pogue, J.; Yusuf, S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am. Heart J., 2005, 149(1), 54-60.
[http://dx.doi.org/10.1016/j.ahj.2004.07.009 ] [PMID: 15660034]
[13]
Marques-Vidal, P.; Jankowski, P.; De Bacquer, D.; Kotseva, K. EUROASPIRE V collaborators. Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V. Int. J. Cardiol., 2020, 302, 5-14.
[http://dx.doi.org/10.1016/j.ijcard.2019.12.064 ] [PMID: 31937454]
[14]
Dehghan, M.; Mente, A.; Teo, K.K.; Gao, P.; Sleight, P.; Dagenais, G.; Avezum, A.; Probstfield, J.L.; Dans, T.; Yusuf, S. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation, 2012, 126(23), 2705-2712.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.103234 ] [PMID: 23212996]
[15]
Ference, B.A.; Ginsberg, H.N.; Graham, I.; Ray, K.K.; Packard, C.J.; Bruckert, E.; Hegele, R.A.; Krauss, R.M.; Raal, F.J.; Schunkert, H.; Watts, G.F.; Borén, J.; Fazio, S.; Horton, J.D.; Masana, L.; Nicholls, S.J.; Nordestgaard, B.G.; van de Sluis, B.; Taskinen, M.R.; Tokgözoglu, L.; Landmesser, U.; Laufs, U.; Wiklund, O.; Stock, J.K.; Chapman, M.J.; Catapano, A.L. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J., 2017, 38(32), 2459-2472.
[http://dx.doi.org/10.1093/eurheartj/ehx144 ] [PMID: 28444290]
[16]
Dauchet, L.; Amouyel, P.; Dallongeville, J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology, 2005, 65(8), 1193-1197.
[http://dx.doi.org/10.1212/01.wnl.0000180600.09719.53 ] [PMID: 16247045]
[17]
Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; Lamuela-Raventos, R.M.; Serra-Majem, L.; Pintó, X.; Basora, J.; Muñoz, M.A.; Sorlí, J.V.; Martínez, J.A.; Martínez-González, M.A. PREDIMED Study Investigators Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med., 2013, 368(14), 1279-1290.
[http://dx.doi.org/10.1056/NEJMoa1200303 ] [PMID: 23432189]
[18]
Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; de Jesus, J.M.; Houston Miller, N.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; Nonas, C.A.; Sacks, F.M.; Smith, S.C., Jr; Svetkey, L.P.; Wadden, T.A.; Yanovski, S.Z.; Kendall, K.A.; Morgan, L.C.; Trisolini, M.G.; Velasco, G.; Wnek, J.; Anderson, J.L.; Halperin, J.L.; Albert, N.M.; Bozkurt, B.; Brindis, R.G.; Curtis, L.H.; DeMets, D.; Hochman, J.S.; Kovacs, R.J.; Ohman, E.M.; Pressler, S.J.; Sellke, F.W.; Shen, W.K.; Smith, S.C., Jr; Tomaselli, G.F. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(25), (Suppl. 2), S76-S99.
[http://dx.doi.org/10.1161/01.cir.0000437740.48606.d1] [PMID: 24222015]
[19]
Butler, T.; Kerley, C.P.; Altieri, N.; Alvarez, J.; Green, J.; Hinchliffe, J.; Stanford, D.; Paterson, K. Optimum nutritional strategies for cardiovascular disease prevention and rehabilitation (BACPR). Heart, 2020, 106(10), 724-731.
[http://dx.doi.org/10.1136/heartjnl-2019-315499 ] [PMID: 32098809]
[20]
Peersen, K.; Munkhaugen, J.; Gullestad, L.; Liodden, T.; Moum, T.; Dammen, T.; Perk, J.; Otterstad, J.E. The role of cardiac rehabilitation in secondary prevention after coronary events. Eur. J. Prev. Cardiol., 2017, 24(13), 1360-1368.
[http://dx.doi.org/10.1177/2047487317719355 ] [PMID: 28664773]
[21]
Wattanasuwan, N.; Khan, I.A.; Gowda, R.M.; Vasavada, B.C.; Sacchi, T.J. Effect of acute myocardial infarction on cholesterol ratios. Chest, 2001, 120(4), 1196-1199.
[http://dx.doi.org/10.1378/chest.120.4.1196 ] [PMID: 11591560]
[22]
Guallar-Castillón, P.; Gil-Montero, M.; León-Muñoz, L.M.; Graciani, A.; Bayán-Bravo, A.; Taboada, J.M.; Banegas, J.R.; Rodríguez-Artalejo, F. Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA Study. Rev. Esp. Cardiol. (Engl. Ed.), 2012, 65(6), 551-558.
[http://dx.doi.org/10.1016/j.rec.2012.03.001 ] [PMID: 22483404]
[23]
Pérez de Isla, L.; Arroyo-Olivares, R.; Muñiz-Grijalvo, O.; Diaz-Díaz, J.L.; Zambón, D.; Fuentes, F.; Sánchez Muñoz-Torrero, J.F.; Mediavilla, J.D.; González-Estrada, A.; Miramontes-González, J.P.; de Andrés, R.; Mauri, M.; Mosquera, D.; Cepeda, J.M.; Suárez, L.; Barba-Romero, M.Á.; Argüeso, R.; Álvarez-Baños, P.; Michán, A.; Romero-Jiménez, M.J.; García-Cruces, J.; Padró, T.; Alonso, R.; Mata, P. Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study. J. Clin. Lipidol., 2019, 13(6), 989-996.
[http://dx.doi.org/10.1016/j.jacl.2019.10.005 ] [PMID: 31706904]
[24]
Kulik, A.; Shrank, W.H.; Levin, R.; Choudhry, N.K. Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am. J. Cardiol., 2011, 107(10), 1409-1414.
[http://dx.doi.org/10.1016/j.amjcard.2011.01.013 ] [PMID: 21414595]
[25]
Lear, S.A.; Spinelli, J.J.; Linden, W.; Brozic, A.; Kiess, M.; Frohlich, J.J.; Ignaszewski, A. The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. Am. Heart J., 2006, 152(2), 333-339.
[http://dx.doi.org/10.1016/j.ahj.2005.12.023 ] [PMID: 16875919]
[26]
DeBusk, R.F.; Miller, N.H.; Superko, H.R.; Dennis, C.A.; Thomas, R.J.; Lew, H.T.; Berger, W.E., III; Heller, R.S.; Rompf, J.; Gee, D.; Kraemer, H.C.; Bandura, A.; Ghandour, G.; Clark, M.; Shah, R.V.; Fisher, L.; Taylor, C.B. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann. Intern. Med., 1994, 120(9), 721-729.
[http://dx.doi.org/10.7326/0003-4819-120-9-199405010-00001 ] [PMID: 8147544]
[27]
Blair, S.N.; Haskell, W.L.; Ho, P.; Paffenbarger, R.S.J., Jr; Vranizan, K.M.; Farquhar, J.W.; Wood, P.D. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am. J. Epidemiol., 1985, 122(5), 794-804.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a114163 ] [PMID: 3876763]
[28]
Berra, K.; Miller, N.H.; Jennings, C. Nurse-based models for cardiovascular disease prevention: from research to clinical practice. Eur. J. Cardiovasc. Nurs., 2011, 10(Suppl. 2), S42-S50.
[http://dx.doi.org/10.1016/S1474-5151(11)00115-0 ] [PMID: 21762851]
[29]
Brügemann, J.; Poels, B.J.J.; Oosterwijk, M.H.; van der Schans, C.P.; Postema, K.; van Veldhuisen, D.J. A randomised controlled trial of cardiac rehabilitation after revascularisation. Int. J. Cardiol., 2007, 119(1), 59-64.
[http://dx.doi.org/10.1016/j.ijcard.2006.07.047 ] [PMID: 17023076]
[30]
Connolly, S.B.; Kotseva, K.; Jennings, C.; Atrey, A.; Jones, J.; Brown, A.; Bassett, P.; Wood, D.A. Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme. Heart, 2017, 103(11), 840-847.
[http://dx.doi.org/10.1136/heartjnl-2016-310477 ] [PMID: 28255098]

Rights & Permissions Print Cite
Article Metrics
21
© 2024 Bentham Science Publishers | Privacy Policy